Eleven Biotherapeutics ophthalmic news

Eleven Biotherapeutics said it will reduce headcount by 14 (70%) to about six. This

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE